Expression of DNA damage response genes indicate progressive breast tumors

Cancer Letters

Volumn 273, Issue 2, 2009, Pages 305-311

  Gochhait, Sailesh ^a   Dar, Surabhi ^a   Pal, Ranjana ^a   Gupta, Pawan ^b   Bamezai, Rameshwar N K ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b Dharamshila Narayana Superspeciality Hospital and Research Centre   (India)

Author keywords

Breast Cancer; DNA damage response; Real time PCR; Transcript level; Western

Indexed keywords

ATM PROTEIN; ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR; PROTEIN MDM2; PROTEIN P21; PROTEIN P53;

ARTICLE; ATM GENE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DNA DAMAGE RESPONSE GENE; FEMALE; GENE EXPRESSION REGULATION; GENE MUTATION; HUMAN; HUMAN TISSUE; MDM2 GENE; ONCOGENE; P21 GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ALLELES; BREAST NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE PROGRESSION; DNA DAMAGE; DNA, COMPLEMENTARY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENETIC MARKERS; HUMANS; PROTO-ONCOGENE PROTEINS C-MDM2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER;

EID: 57349172945     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.08.009     Document Type: Article

References (35)

1. Shiloh Y. The ATM-mediated DNA-damage response: taking shape. Trends Biochem. Sci. 31 (2006) 402-410
2. Nussenzweig A. Causes and consequences of the DNA damage response. Cell Cycle 6 (2007) 2339-2340
3. Risinger M.A., and Groden J. Crosslinks and crosstalk: human cancer syndromes and DNA repair defects. Cancer Cell 6 (2004) 539-545
4. Kastan M.B., and Bartek J. Cell-cycle checkpoints and cancer. Nature 432 (2004) 316-323
5. Sancar A., Lindsey-Boltz L.A., Unsal-Kacmaz K., and Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73 (2004) 39-85
6. Gorgoulis V.G., Vassiliou L.V., Karakaidos P., Zacharatos P., Kotsinas A., Liloglou T., et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434 (2005) 907-913
7. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434 (2005) 864-870
8. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444 (2006) 633-637
9. Cao L., Kim S., Xiao C., Wang R.H., Coumoul X., Wang X., et al. ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency. EMBO J. 25 (2006) 2167-2177
10. Ayyanan A., Civenni G., Ciarloni L., Morel C., Mueller N., Lefort K., et al. Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc. Natl. Acad. Sci. USA 103 (2006) 3799-3804
11. Feng Z., Hu W., Teresky A.K., Hernando E., Cordon-Cardo C., and Levine A.J. Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations. Proc. Natl. Acad. Sci. USA 104 (2007) 16633-16638
12. Hinkal G., and Donehower L.A. Decline and fall of the tumor suppressor. Proc. Natl. Acad. Sci. USA (2007)
13. Ralhan R., Kaur J., Kreienberg R., and Wiesmuller L. Links between DNA double strand break repair and breast cancer: accumulating evidence from both familial and nonfamilial cases. Cancer Lett. 248 (2007) 1-17
14. Russo J., and Russo I.H. The role of estrogen in the initiation of breast cancer. J. Steroid Biochem. Mol. Biol. 102 (2006) 89-96
15. Antoniou A.C., and Easton D.F. Models of genetic susceptibility to breast cancer. Oncogene 25 (2006) 5898-5905
16. Pharoah P.D., Tyrer J., Dunning A.M., Easton D.F., and Ponder B.A. Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet. 3 (2007) e42
17. Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D., Thompson D., Ballinger D.G., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447 (2007) 1087-1093
18. Ribas G., Milne R.L., Gonzalez-Neira A., and Benitez J. Haplotype patterns in cancer-related genes with long-range linkage disequilibrium: no evidence of association with breast cancer or positive selection. Eur. J. Hum. Genet. (2007)
19. Sorlie T., Perou C.M., Fan C., Geisler S., Aas T., Nobel A., et al. Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer. Mol. Cancer Ther. 5 (2006) 2914-2918
20. Lord C.J., Garrett M.D., and Ashworth A. Targeting the double-strand DNA break repair pathway as a therapeutic strategy. Clin. Cancer Res. 12 (2006) 4463-4468
21. Sotiriou C., and Piccart M.J. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?. Nat. Rev. Cancer 7 (2007) 545-553
22. Mir M.M., Dar N.A., Gochhait S., Zargar S.A., Ahangar A.G., and Bamezai R.N. P53 mutation profile of squamous cell carcinomas of the esophagus in Kashmir (India): a high-incidence area. Int. J. Cancer 116 (2005) 62-68
23. Gochhait S., Bukhari S.I., Bairwa N., Raish M., Gupta P., Husain S.A., et al. Implication of BRCA2 -26G > A 5′UTR polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72Arg > Pro polymorphism. Breast Cancer Res. 9 (2007) R71
24. Scott S.P., and Pandita T.K. The cellular control of DNA double-strand breaks. J. Cell. Biochem. (2006)
25. Tommiska J., Bartkova J., Heinonen M., Hautala L., Kilpivaara O., Eerola H., et al. The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer. Oncogene (2007)
26. Li Y., Pan J., Li J.L., Lee J.H., Tunkey C., Saraf K., et al. Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized. Mol. Cancer 6 (2007) 7
27. Christophorou M.A., Ringshausen I., Finch A.J., Swigart L.B., and Evan G.I. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 443 (2006) 214-217
28. Efeyan A., Garcia-Cao I., Herranz D., Velasco-Miguel S., and Serrano M. Tumour biology: policing of oncogene activity by p53. Nature 443 (2006) 159
29. Harris S.L., and Levine A.J. The p53 pathway: positive and negative feedback loops. Oncogene 24 (2005) 2899-2908
30. Soussi T. P53 alterations in human cancer: more questions than answers. Oncogene 26 (2007) 2145-2156
31. Song H., Hollstein M., and Xu Y. P53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nat. Cell Biol. 9 (2007) 573-580
32. Creighton C.J. A gene transcription signature associated with hormone independence in a subset of both breast and prostate cancers. BMC Genomics 8 (2007) 199
33. Bartek J., Lukas J., and Bartkova J. DNA damage response as an anti-cancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'. Cell Cycle 6 (2007) 2344-2347
34. Roylance R., Gorman P., Harris W., Liebmann R., Barnes D., Hanby A., et al. Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res. 59 (1999) 1433-1436
35. Warnberg F., Nordgren H., Bergkvist L., and Holmberg L. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness. Br. J. Cancer 85 (2001) 869-874